Cited 0 times in 
Cited 0 times in 
A multi-institutional, single-arm, phase II trial of neoadjuvant modified-FOLFIRINOX for resectable pancreatic ductal adenocarcinoma
https://orcid.org/0000-0002-5382-4658
https://orcid.org/0000-0002-1595-6342
https://orcid.org/0000-0001-5817-2444
https://orcid.org/0000-0001-5151-5096
https://orcid.org/0000-0003-0952-3679
https://orcid.org/0000-0001-5917-1400
https://orcid.org/0000-0003-4064-7776Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.